News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Bio NC
Salix Pharmaceuticals, Ltd. Reports Digestive Disease Week 2006 UPDATE
May 24, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
RALEIGH, N.C.--(BUSINESS WIRE)--May 24, 2006--Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP - News) today announced results of one investigator-initiated trial of XIFAXAN® (rifaximin) tablets 200 mg presented today at Digestive Disease Week® 2006.
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
CDC
Republicans Ratchet Up Pressure as Monarez Levels Damning Allegations Against Kennedy
September 17, 2025
·
4 min read
·
Heather McKenzie
IN PARTNERSHIP WITH Pii, A JABIL COMPANY
Webinar: Bridging Formulation & Device | Integrated Supply Chain Strategies for US Pharma Manufacturing
September 17, 2025
·
1 min read
·
BioSpace Insights
Obesity
EASD 2025: Orforglipron in Focus, the Case for Cardiovascular Benefits, More
September 15, 2025
·
6 min read
·
Tristan Manalac
Government
Second MAHA Report Emphasizes Chronic Disease, Tilts at Vaccine Reform
September 9, 2025
·
3 min read
·
Heather McKenzie
